Cargando…
Long Term Respiratory Follow-Up for COVID-19 Patients a Multicenter Study
Background: The first wave of the COVID-19 pandemic initiated officially in October 2020. Since then several observations have been made regarding the disease and its symptoms. Patients and Methods: We included eighty seven in our observational study. Our main aim was to investigate their long term...
Autores principales: | BURSAC, DALIBORKA, PETRIDIS, DIMITRIS, ZARIC, BOJAN, KOVACEVIC, TOMI, STOJSIC, VLADIMIR, SARCEV, TATJANA, HUANG, HAIDONG, BAI, CHONG, HOHENFORST-SCHMIDT, WOLFGANG, KOSMIDIS, CHRISTOFOROS, SAPALIDIS, KONSTANTINOS, ROMANIDIS, KONSTANTINOS, COURCOUTSAKIS, NIKOLAOS, LALLAS, AIMILIOS, TSAKALDIMIS, GIORGOS, CHATZIMICHAEL, KYRIAKOULA, SARDELI, CHRYSANTHI, MATTHAIOS, DIMITRIS, ZAROGOULIDIS, PAUL, KARAPANTZOU, CHRYSANTHI |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medical University Publishing House Craiova
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8987475/ https://www.ncbi.nlm.nih.gov/pubmed/35444815 http://dx.doi.org/10.12865/CHSJ.47.04.05 |
Ejemplares similares
-
Personalized Approach to Tissue and Liquid Biopsy after Failure of First-Line EGFR-TKIs: Is There an Issue When Tissue Is Not the Issue? A Case Series
por: Bursac, Daliborka, et al.
Publicado: (2021) -
Intratumoral Treatment with Chemotherapy and Immunotherapy for NSCLC with EBUS-TBNA 19G
por: Zarogoulidis, Paul, et al.
Publicado: (2021) -
Priority of PET-CT vs CT Thorax for EBUS-TBNA 22G vs 19G: Mesothorax Lymphadenopathy
por: Zarogoulidis, Paul, et al.
Publicado: (2021) -
Lung cancer biopsies: Comparison between simple 22G, 22G upgraded and 21G needle for EBUS-TBNA
por: Zarogoulidis, Paul, et al.
Publicado: (2020) -
Producing the appropriate model and drug for intratumoural ablation
por: Kosmidis, Christoforos, et al.
Publicado: (2020)